Biosensors & POCT– category –
-
Cohort Study Confirms Primary Care-Initiated Continuous Glucose Monitoring Significantly Improves HbA1c and Reduces Hospitalizations in Insulin-Treated Diabetics
JAMA Network Open USA Overview A new cohort study published in JAMA Network Open demonstrates that initiating Continuous Glucose Monitoring (CGM) in insulin-treated adults with diabetes through primary care clinicians leads to clinically... -
Clair Health Secures $11.6 Million for Wearable Biosensor Device to Deliver Non-Invasive Continuous Hormone Monitoring
OpenLoop Health USA Overview Women's health startup Clair Health has successfully raised $11.6 million in funding to accelerate the development of a wearable device for continuous, non-invasive hormone monitoring. This innovative device ... -
Digital Health in July 2026: AI Wearables Monitor Hormonal Changes, Flexible Computing Patch Detects Life-Threatening Cardiac Arrhythmias with 99.6% Accuracy
MarketScale USA Overview Digital health trends in July 2026 showcase innovative AI wearables. Clair Health completed an $11.6 million funding round for a wearable device monitoring hormonal changes without blood tests, combining 10 biose... -
Future of Non-Invasive Blood Sugar Monitoring: High-Sensitivity Biosensors Detect Glucose in Sweat, Saliva, and Tears
Science Insight Global Overview This article envisions the future of non-invasive blood sugar monitoring, focusing on the development of high-sensitivity biosensors capable of detecting glucose in sweat, saliva, and tears. The concept of... -
ARPA-H-Funded COSMIC Team Develops Closed-Loop Tear Biosensor System for Real-Time Drug Delivery and Disease Monitoring; Faces Complex FDA Path as a Combination Product
Eye Care Network - Ophthalmology Times USA Overview The ARPA-H-funded COSMIC team, led by Dr. Dipanjan Pan at Penn State University, is conducting early-stage research on a closed-loop tear biosensor system. This system aims for continuo... -
Roche Diagnostics Expands Focus on Diabetes Care, Awaiting US Approval for Accu-Chek Smartguide CGM
Indianapolis Business Journal USA Overview Swiss pharmaceutical giant Roche is continuing its expansion project within its diagnostics division in Indianapolis, with an intensified focus on diabetes care. The company is particularly awai... -
UMass Chan Medical School Launches PILLAR Project: Remote Monitoring System for Lupus Patients Integrates Wearables and AI to Track Symptoms and Biomarkers
University of Massachusetts Chan Medical School USA Overview The University of Massachusetts Chan Medical School is developing the PILLAR project, a remote patient monitoring (RPM) system to improve care for systemic lupus erythematosus ... -
Novel Plasmonic Sensor Detects Aflatoxin M1 Contamination in Milk at 0.005 ng/mL, Enhancing Food Safety Monitoring
AZoSensors Australia Overview A new plasmonic graphene oxide-based aptasensor has been reported to detect Aflatoxin M1 (AFM1) contamination in milk at ultra-low concentrations of 0.005 ng/mL. This innovative sensor significantly enhances... -
Synergistic Optimization Strategy for High-Performance Multilayer SPR Biosensor Dramatically Boosts Sensitivity for Urinary Glucose Detection in Diabetes Diagnosis
Optica Publishing Group USA Overview This study proposes a highly sensitive Surface Plasmon Resonance (SPR) biosensor with a ZnO/Au/Ag/Si/WSe2 multilayer configuration for urinary glucose detection in diabetes diagnosis. Simulation resul... -
Advances in Optical Fiber Sensors for Multi-Analyte Biochemical Detection: High Sensitivity, Low Detection Limits, and Real-Time Capabilities for Multi-Gas Monitoring
MDPI Switzerland Overview This paper highlights advancements in optical fiber sensors for multi-analyte biochemical detection. Optical fiber multi-analyte biochemical sensors enable simultaneous detection of multiple biomarkers and prote...
